ACC |
Adrenocortical carcinoma |
AUC |
Area under the curve |
AI |
Artificial intelligence |
CGGA |
Chinese Glioma Genome Atlas |
COAD |
Colon adenocarcinoma |
cDC1 |
Conventional dendritic cells 1 |
CRCA |
COAD + rectum adenocarcinoma |
DC |
Dendritic cells |
DFI |
Disease-free interval |
DSS |
Disease-specific survival |
DSP |
Disulfidptosis |
DRGs |
Disulfidptosis-related genes |
Edu |
5-ethynyl-2′-deoxyuridine |
GEO |
Gene expression omnibus |
GBM |
Glioblastoma multiforme |
HR |
Hazard Ratio |
HNSC |
Head and neck squamous cell carcinoma |
ICIs |
Immune checkpoint inhibitors |
ICD |
Immunogenic cell death |
ICGC |
International Cancer Genome Consortium |
KCA |
Kidney carcinoma |
KICH |
Kidney chromophobe |
KIRC |
Kidney renal clear cell carcinoma |
LASSO |
Least absolute shrinkage and selection operator |
LUAD |
Lung adenocarcinoma |
LCA |
Lung carcinoma |
DLBC |
Lymphoid neoplasm diffuse large B-cell lymphoma |
ML |
Machine learning |
NADPH |
Nicotinamide adenine dinucleotide phosphate |
NMF |
Non-negative matrix factorization |
OS |
Overall survival |
PBMC |
peripheral blood mononuclear cells |
PCPG |
Pheochromocytoma and paraganglioma |
PFI |
Progression-free interval |
PRAD |
Prostate adenocarcinoma |
ROC |
Receiver operating characteristic |
RCD |
Regulated cell death |
ssGSEA |
Single-sample Gene Set Enrichment Analysis |
siRNA |
Small interfering RNA |
STAD |
Stomach adenocarcinoma |
Tex |
T cell exhaustion |
TCGA |
The Cancer Genome Atlas |
TCIA |
The Cancer Immunome Atlas |
THCA |
Thyroid cancer |
THYM |
Thymoma |
TDG |
Tumor driver genes |
TME |
Tumor microenvironment |
TMB |
Tumor mutation burden |
UCEC |
Uterine corpus endometrial carcinoma |
UVM |
Uveal melanoma |
WGCNA |
Weighted correlation network analysis |